Review article · 2010

Patient-reported outcomes in support of oncology product labeling claims: regulatory context and challenges

Yanni Hao

Expert Review of Pharmacoeconomics & Outcomes Research, 10(4), 407–420 · Published 1 August 2010 · DOI 10.1586/erp.10.45

View at the publisherCite this paper

In brief

“Patient-reported outcomes in support of oncology product labeling claims: regulatory context and challenges” is a 2010 review article by Yanni Hao, published in Expert Review of Pharmacoeconomics & Outcomes Research. OpenAlex counts 20 citations as of 22 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
20
Most cited in
2016 (4)
Field-weighted impact
0.36
References
48
Authors
1

Abstract

The US FDA has advocated the patient-reported outcome (PRO) draft guidance as the main vehicle for evaluating PRO-based labeling claims for oncology drugs. In addition, FDA-affiliated researchers have identified factors inhibiting acceptance of health-related quality of life (HRQoL)-based claims for oncology product labels. The views of the FDA on PRO claims are extensive and prescriptive.… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Hao, Y. (2010). Patient-reported outcomes in support of oncology product labeling claims: regulatory context and challenges. Expert Review of Pharmacoeconomics & Outcomes Research, 10(4), 407–420. https://doi.org/10.1586/erp.10.45

MLA 9

Hao, Yanni. “Patient-reported outcomes in support of oncology product labeling claims: regulatory context and challenges.” Expert Review of Pharmacoeconomics & Outcomes Research, vol. 10, no. 4, 2010, pp. 407–420. https://doi.org/10.1586/erp.10.45.

Chicago

Hao, Yanni. 2010. “Patient-reported outcomes in support of oncology product labeling claims: regulatory context and challenges.” Expert Review of Pharmacoeconomics & Outcomes Research 10 (4): 407–420. https://doi.org/10.1586/erp.10.45.

Harvard

Hao, Y. (2010) ‘Patient-reported outcomes in support of oncology product labeling claims: regulatory context and challenges’, Expert Review of Pharmacoeconomics & Outcomes Research, 10(4), pp. 407–420. doi:10.1586/erp.10.45.

IEEE

Y. Hao, “Patient-reported outcomes in support of oncology product labeling claims: regulatory context and challenges,” Expert Review of Pharmacoeconomics & Outcomes Research, vol. 10, no. 4, pp. 407–420, 2010, doi: 10.1586/erp.10.45.

BibTeX

@article{hao2010patient,
  title     = {{Patient-reported outcomes in support of oncology product labeling claims: regulatory context and challenges}},
  author    = {Hao, Yanni},
  journal   = {Expert Review of Pharmacoeconomics \& Outcomes Research},
  year      = {2010},
  volume    = {10},
  number    = {4},
  pages     = {407--420},
  doi       = {10.1586/erp.10.45},
  url       = {https://doi.org/10.1586/erp.10.45}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201233
201322
201433
201522
201644
201711
201811
202011
202222
202311

Its field-weighted citation impact is 0.36: it has been cited 0.36 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life

  • patient-reported outcomes
  • health-related quality of life
  • FDA draft guidance
  • European Medicines Agency
  • trial design
  • missing data

Work with this paper

Most-cited papers in Economics, Econometrics and Finance

All highly cited Economics, Econometrics and Finance papers

Questions about this paper

How do I cite this paper in APA style?

Hao, Y. (2010). Patient-reported outcomes in support of oncology product labeling claims: regulatory context and challenges. Expert Review of Pharmacoeconomics & Outcomes Research, 10(4), 407–420. https://doi.org/10.1586/erp.10.45

How many times has this paper been cited?

20 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Yanni Hao.

What is the DOI of this paper?

10.1586/erp.10.45, permanently at https://doi.org/10.1586/erp.10.45. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.